Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis across different regions of China: a post-hoc exploratory analysis of a phase III, randomized controlled trial
The efficacy and safety of vunakizumab are not affected by different regions of China in patients with moderate-to-severe plaque psoriasis.
Authors
- Ying‐Jie Zhu (ORCID: https://orcid.org/0000-0002-5044-5046)
- Qiaoli Zheng (ORCID: https://orcid.org/0000-0001-8608-0707)
- Xia Wu (ORCID: https://orcid.org/0000-0002-8151-8076)
- Hao Cheng
- Kejian Zhu
Institutions
- Sir Run Run Shaw Hospital (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1080/09546634.2025.2560505
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00